(147 days)
Not Found
No
The description focuses on the physical and chemical processes of oxygen concentration and sensing, with no mention of AI or ML algorithms for data analysis, decision-making, or performance optimization.
Yes
The device is used by patients requiring supplemental oxygen to treat their condition, indicating a therapeutic purpose.
No
The device provides oxygen to the patient and does not diagnose disease or conditions.
No
The device description clearly outlines hardware components and physical processes (molecular sieve, pressure swing adsorption, sensing pressure change, regenerating oxygen pulse) that are integral to its function. It is a physical medical device that utilizes these hardware components to deliver oxygen.
Based on the provided information, the Aer X oxygen concentrator device is not an IVD (In Vitro Diagnostic).
Here's why:
- IVD Definition: In Vitro Diagnostics are medical devices used to perform tests on samples taken from the human body (like blood, urine, tissue) to provide information about a person's health.
- Aer X Function: The Aer X oxygen concentrator is a device that delivers oxygen to a patient. It works by processing ambient air to concentrate oxygen and then providing that oxygen to the patient through a nasal cannula. It does not perform any tests on samples from the patient's body.
- Intended Use: The intended use clearly states it's for "patients requiring supplemental oxygen" and "supplies a high concentration of oxygen." This is a therapeutic function, not a diagnostic one.
Therefore, the Aer X oxygen concentrator falls under the category of a therapeutic medical device, not an In Vitro Diagnostic device.
N/A
Intended Use / Indications for Use
The Aer X oxygen concentrator device is used on a prescriptive basis by patients requiring supplemental oxygen. It supplies a high concentration of oxygen and is used with a nasal cannula to channel oxygen from the concentrator to the patient. The Aer X may be used in home, institution, vehicle and various mobile environments.
Product codes (comma separated list FDA assigned to the subject device)
CAW
Device Description
The Aer X oxygen concentrator utilies a molecular sieve and a differential pressure swing adsorption methodology to separate the gases in ambient air. The device takes the room air and concentrates the oxygen portion to produce a pulseof oxygen between 87-94% in purity. When the patient inhales, the device senses the pressure change and is triggered to release the oxygen pulse. In between breaths, the device regenerates an oxygen pulse and waits for the next inhalation breath before dispensing it
Mentions image processing
Not Found
Mentions AI, DNN, or ML
Not Found
Input Imaging Modality
Not Found
Anatomical Site
Not Found
Indicated Patient Age Range
Not Found
Intended User / Care Setting
Used on a prescriptive basis by patients requiring supplemental oxygen. May be used in home, institution, vehicle and various mobile environments.
Description of the training set, sample size, data source, and annotation protocol
Not Found
Description of the test set, sample size, data source, and annotation protocol
Not Found
Summary of Performance Studies (study type, sample size, AUC, MRMC, standalone performance, key results)
Non-clinical testing (Bench testing) was performed to provide assurance that the proposed device confirm to the requirements for its intended use. This include the following:
- Output gas composition (e.g. VOCs, particulate matter, ozone/carbon monoxide/carbon dioxide content).
- User display and LED functions
- Oxygen flow rate and concentration
- Electromagnetic compatibility and electrical safety
- Functional performance
- Output gas temperature.
To verify that the modified device design met its functional and performance requirements, representative samples of the device underwent biocompatibility, electrical, and mechanical testing in accordance with applicable industry standards: IEC 60601-1, IEC 60601-1-2, IEC 60601-1-6, IEC 60601-1-8, IEC 60601-1-11, and ISO 80601-2-69.
Key Metrics (Sensitivity, Specificity, PPV, NPV, etc.)
Not Found
Predicate Device(s): If the device was cleared using the 510(k) pathway, identify the Predicate Device(s) K/DEN number used to claim substantial equivalence and list them here in a comma separated list exactly as they appear in the text. List the primary predicate first in the list.
Reference Device(s): Identify the Reference Device(s) K/DEN number and list them here in a comma separated list exactly as they appear in the text.
Not Found
Predetermined Change Control Plan (PCCP) - All Relevant Information for the subject device only (e.g. presence / absence, what scope was granted / cleared under the PCCP, any restrictions, etc).
Not Found
§ 868.5440 Portable oxygen generator.
(a)
Identification. A portable oxygen generator is a device that is intended to release oxygen for respiratory therapy by means of either a chemical reaction or physical means (e.g., a molecular sieve).(b)
Classification. Class II (performance standards).
0
Image /page/0/Picture/0 description: The image shows the logo of the U.S. Food and Drug Administration (FDA). On the left is the seal of the Department of Health & Human Services. To the right of that is the FDA logo in blue, with the words "U.S. FOOD & DRUG" stacked on top of the word "ADMINISTRATION".
3B Medical Inc. Yasser Estafanous QA/RA Director 203 Avenue A NW, Suite 300 Winter Haven, Florida 33881
Re: K200496
Trade/Device Name: Aer X Regulation Number: 21 CFR 868.5440 Regulation Name: Portable Oxygen Generator Regulatory Class: Class II Product Code: CAW Dated: June 22, 2020 Received: June 24, 2020
Dear Yasser Estafanous:
We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. Although this letter refers to your product as a device, please be aware that some cleared products may instead be combination products. The 510(k) Premarket Notification Database located at https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfpmn/pmn.cfm identifies combination product submissions. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration. Please note: CDRH does not evaluate information related to contract liability warranties. We remind you, however, that device labeling must be truthful and not misleading.
If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register.
Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's
1
requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Part 801); medical device reporting of medical device-related adverse events) (21 CFR 803) for devices or postmarketing safety reporting (21 CFR 4, Subpart B) for combination products (see https://www.fda.gov/combination-products/guidance-regulatory-information/postmarketing-safety-reportingcombination-products); good manufacturing practice requirements as set forth in the quality systems (OS) regulation (21 CFR Part 820) for devices or current good manufacturing practices (21 CFR 4, Subpart A) for combination products; and, if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act); 21 CFR 1000-1050.
Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21 CFR Part 807.97). For questions regarding the reporting of adverse events under the MDR regulation (21 CFR Part 803), please go to https://www.fda.gov/medical-device-safety/medical-device-reportingmdr-how-report-medical-device-problems.
For comprehensive regulatory information about mediation-emitting products, including information about labeling regulations, please see Device Advice (https://www.fda.gov/medicaldevices/device-advice-comprehensive-regulatory-assistance) and CDRH Learn (https://www.fda.gov/training-and-continuing-education/cdrh-learn). Additionally, you may contact the Division of Industry and Consumer Education (DICE) to ask a question about a specific regulatory topic. See the DICE website (https://www.fda.gov/medical-device-advice-comprehensive-regulatoryassistance/contact-us-division-industry-and-consumer-education-dice) for more information or contact DICE by email (DICE@fda.hhs.gov) or phone (1-800-638-2041 or 301-796-7100).
Sincerely,
Todd Courtney Assistant Director DHT1C: Division of ENT, Sleep Disordered Breathing, Respiratory and Anesthesia Devices OHT1: Office of Ophthalmic, Anesthesia, Respiratory, ENT and Dental Devices Office of Product Evaluation and Quality Center for Devices and Radiological Health
Enclosure
2
Indications for Use
510(k) Number (if known) K200496
Device Name Aer X
Indications for Use (Describe)
The Aer X oxygen concentrator device is used on a prescriptive basis by patients requiring supplemental oxygen. It supplies a high concentration of oxygen and is used with a nasal cannula to channel oxygen from the concentrator to the patient. The Aer X may be used in home, institution, vehicle and various mobile environments.
| Type of Use (Select one or both, as applicable) | |
|---|---|
| Prescription Use (Part 21 CFR 801 Subpart D) | Over-The-Counter Use (21 CFR 801 Subpart C) |
CONTINUE ON A SEPARATE PAGE IF NEEDED.
This section applies only to requirements of the Paperwork Reduction Act of 1995.
DO NOT SEND YOUR COMPLETED FORM TO THE PRA STAFF EMAIL ADDRESS BELOW.
The burden time for this collection of information is estimated to average 79 hours per response, including the time to review instructions, search existing data sources, gather and maintain the data needed and complete and review the collection of information. Send comments regarding this burden estimate or any other aspect of this information collection, including suggestions for reducing this burden, to:
Department of Health and Human Services Food and Drug Administration Office of Chief Information Officer Paperwork Reduction Act (PRA) Staff PRAStaff(@fda.hhs.gov
"An agency may not conduct or sponsor, and a person is not required to respond to, a collection of information unless it displays a currently valid OMB number."
3
Image /page/3/Picture/1 description: The image shows the logo for 3B Medical. The logo consists of the text "3B Medical" in a blue, sans-serif font. To the left of the text is a stylized graphic of three concentric arcs, also in blue, that appear to be orbiting the "3B" portion of the text. The "TM" symbol is located to the upper right of the "3B".
510(k) Summary
| Submitter: | 3B Medical Inc.
203 Avenue A NW Suite 300
Winter Haven, FL 33881 |
|----------------------|-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| Contact Person: | Yasser Estafanous
Director of QA/RA
Telephone: 863-226-6285
Fax: 863-226-6284
Email: yestafanous@3bproducts.com |
| Date Prepared: | July 17, 2020 |
| Trade Name: | Aer X Portable Oxygen Concentrator |
| Common Name: | Oxygen Concentrator |
| Classification: | Class II |
| Product Code: | CAW, 21 CFR 868.5440 |
| Predicate Device(s): | The subject device is equivalent to the following devices:
• VBOX Trooper (K121260) |
| Device Description: | The Aer X oxygen concentrator utilies a molecular sieve and a
differential pressure swing adsorption methodology to separate
the gases in ambient air. The device takes the room air and
concentrates the oxygen portion to produce a pulseof oxygen
between 87-94% in purity. When the patient inhales, the device
senses the pressure change and is triggered to release the oxygen
pulse. In between breaths, the device regenerates an oxygen
pulse and waits for the next inhalation breath before dispensing
it |
4
Image /page/4/Picture/1 description: The image shows the logo for 3B Medical. The logo is in blue and features the text "3B Medical". To the left of the text is a circular design with three curved lines that resemble a globe. The logo is simple and modern.
Comparison to the Predicate Device
Table 1. Comparison to Predicate Device
| | Aer X Oxygen Concentrator
(Subject Device) | VBOX Trooper Oxygen
Concentrator
(Predicate Device) |
|-----------------------------------------|------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| 510(k) Number | K200496 | K121260 |
| Decision Date | | |
| Manufacturer | 3B Medical Inc. | VBOX |
| Classification | Class II | Class II |
| Product Code | CAW | CAW |
| Regulation | 21 CFR 868.5440 | 21 CFR 868.5440 |
| Indications for Use | The Aer X oxygen concentrator
device is used on a prescriptive
basis by patients requiring
supplemental oxygen. It
supplies a high concentration of
oxygen and is used with a nasal
cannula to channel oxygen from
the concentrator to the patient.
The Aer X may be used in
home, institution, vehicle and
various mobile environments. | The Trooper oxygen
concentrator device is used on a
prescriptive basis by patients
requiring supplemental oxygen.
It supplies a high concentration
of oxygen and is used with a
nasal cannula to channel
oxygen from the concentrator to
the patient. The Trooper may be
used in home, institution,
vehicle and various mobile
environments. |
| Prescription Required | Yes | Yes |
| Patient Interface | Same Standard nasal Cannula | Standard nasal cannula |
| Dimensions (LxWxH) | 7.125"x8.25"x2.75"inches | 6 x 2.5 x 6.25 inches |
| Weight | 4.2 lbs (includes battery) | 3.2 lbs (includes battery) |
| Materials | | |
| Sieve Bed | Synthetic zeolite | Synthetic zeolite |
| Sieve bed cartridge | Adsorbent Cartiradges | Adsorbent Cartiradges |
| Battery | Li-Ion | Li-Ion |
| Performance Specifications | | |
| Method of oxygen
concentration | Molecular sieve (mechanical) | Molecular sieve (mechanical) |
| Process by which
Oxygen is released | Differential pressure swing
adsorption | Differential pressure swing
adsorption |
| Flow Rate | 5 settings: 1 to 5 (flow rates
equivalent to 1 LPM to 5 LPM) | 5 settings: 1 to 5 (flow rates
equivalent to 1 LPM to 5 LPM) |
| Duration of flow | Pulsed | Pulsed |
| Trigger Sensitivity | 0.13 cm water (12.7 Pa) | 0.13 cm water (12.7 Pa) |
| Oxygen concentration
(% O2) | 87-94% at all settings | 87-94% at all settings |
| Software/ Hardware | Analog and digital electronics
with microprocessor | Analog and digital electronics
with microprocessor |
| Rechargeable Battery | Yes | Yes |
| Power Options | Battery, AC | Battery, AC |
| Technological charactartristics Summary | | |
| Produce of high purity
O2 | Differential pressure vacuum
swing adsorption method | Differential pressure vacuum
swing adsorption method |
| Flow | Pulsed | Pulsed |
| Cycles to produce
concentrated O2 | 1) Dispense, 2) Evacuate and 3)
Pressurize | 1) Dispense, 2) Evacuate and 3)
Pressurize |
| Material inside
adsorbent cartridge | Synthetic Zeolite | Synthetic Zeolite |
5
Image /page/5/Picture/1 description: The image shows the logo for 3B Medical. The logo consists of the text "3B Medical" in a blue sans-serif font. To the left of the text is a stylized graphic of three concentric circles, also in blue. The letters "3B" are inside the circles, and the letters "TM" are in superscript to the right of the "B".
Table 1. Comparison to Predicate Device
A summary of technological Characteristics of the new device in comparison to those of the predicate device.
New Changes to the Aer X as compared to the VBOX TROOPER
1.Exterior Shape- The exterior housing shape was required to change due to the Battery change below and the Keypad/ Display change below. The material for the exterior housing is PolyCarb/ ABS with the same fire-retardant rating as was the original device.
-
Battery Location changed from an exterior position with cord and plug to an integrated separate battery chamber with protected style of plug that does not require user to maneuver the plug into position.
-
LCD display with Keypad was updated to more tactile buttons and a color LCD in place of a segmented display.
-
Magnetic Cannula is a new feature to create a "breakaway" cannula that will protect the user and device in the event of the cannula tubing being "caught" on an object. The shape of the cannula plug is shaped to fit the industry standard cannula profile. The cannula plug was also changed to anodized aluminum to keep with industry standards for that component.
-
new design for the Carry Bag needed to change to fit the new exterior shape, also to have a flap that covers the display keypad.
6
Image /page/6/Picture/1 description: The image shows the logo for 3B Medical. The logo consists of the text "3B Medical" in a blue sans-serif font. To the left of the text is a circular graphic made of blue lines that appear to be emanating from a central point. The "TM" symbol is located to the upper right of the "3B" text.
Technology not changed:
- . Battery Power: 18650 Li Ion cells in a battery Pack that is user changeable and user chargeable, as before.
- . O2 Production-Separation uses the same Vacuum Pressure swing, purge and repressurizing algorithm employing LILSX adsorbent with high nitrogen capacity. Valving and timing to provide purge and blow down technology is also employed, as before.
- O2 Product Flow Rate: Oxygen is delivered by the Aer X device via a nasal cannula the same standard 2 prong cannula, the Oxygen is delivered in pulse mode a bolus of oxygen at the beginning of each inhalation. The purity of the oxygen is 90% +4% -3% (87-94%) which is also an industry standard for portable oxygen concentrators. The oxygen flow rate is in 5 settings 1 to 5 to be equivalent to 1 LPM to 5 LPM.
To verify that the modified device design met it's functional and Functional and performance requirements, representative samples of the device Safety Testing: underwent biocompatibility, electrical, and mechanical testing in accordance with applicable industry standards: IEC 60601-1, IEC 60601-1-2, IEC 60601-1-6, IEC 60601-1-8, IEC 60601-1-11, and ISO 80601-2-69.
Non-clinical testing(Bench testing)
Bench testing was performed to provide assurance that the proposed device confirm to the requirements for its intended use. This include the following
- . Output gas composition (e.g. VOCs, particulate matter, ozone/carbon monoxide/carbon dioxide content).
- User display and LED functions
- Oxygen flow rate and concentration
- Electromagnetic compatibility and electrical safety
- Functional performance ●
- Output gas temperature.
7
Image /page/7/Picture/1 description: The image shows the logo for 3B Medical. The logo consists of the text "3B Medical" in blue font. To the left of the text is a circular graphic made of curved blue lines. The "TM" symbol is located to the upper right of the "3B" text.
Summary of results :
As outlined above, the principles of operation, technology, materials and indications for use of the subject device are equivalent to those of the predicate device. The differences in size, weight, LCD & Keypad, exterior housing, carry bag, and the cannula port do not introduce any different questions of safety and effectiveness over the predicate device. The information demonstrates that the subject device is substantially equivalent to the predicate device.